Desferrioxamine (deferoxamine)
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Desferrioxamine (deferoxamine) and local guidelines before prescribing.
Mechanism
Iron chelator.
Uses
Acute iron poisoning, chronic iron overload.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hypotension with rapid infusion, hearing and visual loss, infection (Yersinia), rash.
Interactions
Vitamin C with caution in heart disease.
Contraindications and cautions
Anuria
Monitoring
BP, iron levels
Pregnancy and breastfeeding
Use if essential
Renal and hepatic impairment
Dose-adjust in renal impairment
Overdose and reversal
Supportive
Special advice
Pink or vin-rose urine indicates iron excretion; indicated for significant iron poisoning per toxicology advice.
More from the textbook: uses, cautions and other points
- Desferrioxamine - SC infusion over 8–12 hours on most nights; eye and hearing toxicity (yearly checks), Yersinia infection (stop if fever with abdominal pain or diarrhoea), slowed growth in children.
Haematology: Anatomy Physiology and Pharmacology - Desferrioxamine - subcutaneous infusion over 8–12 hours, 5–7 nights a week. Side effects: hearing and vision problems, Yersinia infection.
Haematology: Haemoglobinopathies and Transfusion - Desferrioxamine / deferasirox / deferiprone | Iron chelation. Deferiprone - agranulocytosis (weekly FBC); deferasirox - kidney and liver toxicity.
Haematology: Haemoglobinopathies and Transfusion - Transfusional overload: Chelation with desferrioxamine, deferasirox or deferiprone; intensified combination chelation for cardiac iron.
Cardiology: Cardiomyopathies - Chelation (desferrioxamine) if venesection is not possible.
Gastroenterology: Liver disease - Overdose - dangerous, especially in children (vomiting, GI bleeding, shock, liver failure) - TOXBASE; desferrioxamine.
Haematology: Anatomy Physiology and Pharmacology - Desferrioxamine / deferasirox / deferiprone | Iron chelation; eyes, ears, Yersinia / kidney, liver / agranulocytosis (weekly FBC).
Haematology: Anatomy Physiology and Pharmacology - Risk factors - diabetic ketoacidosis and poorly controlled diabetes, neutropenia, high-dose steroids, iron overload (desferrioxamine), transplant.
ID: Viral, fungal and parasitic infections
Where it is discussed in the book
- Cardiology: Cardiomyopathies (1 mention)
- Gastroenterology: Liver disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (3 mentions)
- Haematology: Haemoglobinopathies and Transfusion (2 mentions)
- ID: Viral, fungal and parasitic infections (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (3 mentions)
- Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders (1 mention)
- Integrated cardiology chapter (1 mention)
- Biochemistry: Enzymes, vitamins and trace elements (1 mention)
- Microbiology: Fungi, parasites and travel-related infection (1 mention)